Literature DB >> 10209006

Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis.

N Akhtar1, J Ni, D Stromberg, G L Rosenthal, N E Bowles, J A Towbin.   

Abstract

BACKGROUND: Infectious respiratory disorders are important causes of childhood morbidity and mortality. Viral causes are common and may lead to rapid deterioration, requiring mechanical ventilation; myocardial dysfunction may accompany respiratory decompensation. The etiologic viral diagnosis may be difficult with classic methods. The purpose of this study was to evaluate polymerase chain reaction (PCR) as a diagnostic method for identification of causative agents. METHODS AND
RESULTS: PCR was used to amplify sequences of viruses known to cause childhood viral pneumonia and myocarditis. Oligonucleotide primers were designed to amplify specific sequences of DNA virus (adenovirus, cytomegalovirus, herpes simplex virus, and Epstein-Barr virus) and RNA virus (enterovirus, respiratory syncytial virus, influenza A, and influenza B) genomes. Tracheal aspirate samples were obtained from 32 intubated patients and nucleic acid extracted before PCR. PCR results were compared with results of culture, serology, and antigen detection methods when available. In cases of myocarditis (n=7), endomyocardial biopsy samples were analyzed by PCR and compared with tracheal aspirate studies. PCR amplification of viral genome occurred in 18 of 32 samples (56%), with 3 samples PCR positive for 2 viral genomes. Amplified viral sequences included RSV (n=3), enterovirus (n=5), cytomegalovirus (n=4), adenovirus (n=3), herpes simplex virus (n=2), Epstein-Barr virus (n=1), influenza A (n=2), and influenza B (n=1). All 7 cases of myocarditis amplified the same viral genome from heart as found by tracheal aspirate.
CONCLUSIONS: PCR is a rapid and sensitive diagnostic tool in cases of viral pneumonia with or without myocarditis, and tracheal aspirate appears to be excellent for analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209006     DOI: 10.1161/01.cir.99.15.2011

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  Heart failure in the young.

Authors:  Michael Burch
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

2.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Lethal influenza B myocarditis in a child and review of the literature for pediatric age groups.

Authors:  H Frank; C Wittekind; U G Liebert; M Siekmeyer; W Siekmeyer; V Schuster; W Kiess
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

Review 4.  Diagnosis and management of pediatric myocarditis.

Authors:  Desmond Bohn; Lee Benson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease.

Authors:  Cristina Basso; Fiorella Calabrese; Annalisa Angelini; Elisa Carturan; Gaetano Thiene
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 6.  An approach to the treatment of pediatric myocarditis.

Authors:  Daniel Levi; Juan Alejos
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Molecular Aspects of Myocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.663

8.  Clinical outcome of acute myocarditis in children according to treatment modalities.

Authors:  Hyun Jung Kim; Gyeong-Hee Yoo; Hong Ryang Kil
Journal:  Korean J Pediatr       Date:  2010-07-31

9.  Diagnostic value of real-time polymerase chain reaction to detect viruses in young children admitted to the paediatric intensive care unit with lower respiratory tract infection.

Authors:  Alma C van de Pol; Tom F W Wolfs; Nicolaas J G Jansen; Anton M van Loon; John W A Rossen
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  Complete Genome Sequence of Human Respiratory Syncytial Virus Isolated in Mexico.

Authors:  J E Muñoz-Medina; I E Monroy-Muñoz; A Santos Coy-Arechavaleta; A Meza-Chávez; J Ángeles-Martínez; Y M Anguiano-Hernández; C E Santacruz-Tinoco; J González-Ibarra; B Martínez-Miguel; J E Alvarado-Yaah; I D Palomec-Nava; J M Ortiz-Alcántara; F Garcés-Ayala; J E Ramírez-González; J A Díaz-Quiñonez; C R González-Bonilla
Journal:  Genome Announc       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.